þ (IKCa1) channels play a critical role in the development of EC. The expression of IKCa1 at both mRNA and protein levels in EC tissues was greatly increased than that in atypical hyperplasia and normal tissues. Treatment of EC cells with clotrimazole and TRAM-34, two agents known to inhibit IKCa1 channels, suppressed the proliferation of EC cells and blocked EC cell cycle at G 0 /G 1 phase. Similarly, downregulation of IKCa1 by siRNA against IKCa1 inhibited EC cell proliferation and arrested its cell cycle at G 0 /G 1 phase. A clotrimazole-sensitive K þ current was induced in EC cells in response to the increased Ca 2 þ . The current density induced by Ca 2 þ was greatly reduced by clotrimazole, TRAM-34, charybdotoxin or downregulation of IKCa1 by the siRNA against IKCa1. Furthermore, TRAM-34 and clotrimazole slowed the formation in nude mice of tumor generated by injection of EC cells. Our results suggest that increased activity of IKCa1 channel is necessary for the development of EC. Oncogene (2007) 26, 5107-5114; doi:10.1038 
Introduction
Endometrial cancer (EC) is the most common malignancy of the female genital tract and the fourth most common malignancy in women in the developed world after breast, colorectal and lung cancer (Levine and Hoskins, 2002; Ryan et al., 2005; Schneider et al., 2005) . The incidence is estimated at 15-20 per 100 000 women per year. Many patients with EC respond poorly to chemotherapy and radiotherapy. Therefore, to understand the mechanism by which EC develops is necessary for an efficient and specific inhibition of the progression of this form of cancer.
Ion channels, including K þ channels, are important for cell cycle and cell proliferation and are found in a variety of cancer cells (Nilius and Wohlrab, 1992; Skryma et al., 1997; Ouadid-Ahidouch et al., 2000; Fraser et al., 2003; Parihar et al., 2003; Farias et al., 2004; Jager et al., 2004) . It has been shown that K þ channels play a role in controlling proliferation and transformation of epithelial cells (Pardo et al., 1999) . They might be considered as potential markers for molecular staging and targets for development of anticancer therapeutic strategies (Smith et al., 2002) . In addition, K þ channels also control cell volume to modulate cell proliferation (Rouzaire-Dubois and Dubois, 1998; Lang et al., 2003) .
Increased expression of IKCa1 channels, a member of the Ca 2 þ -activated K þ channel superfamily, is found in pancreatic cancer tissue. Inhibition of the IKCa1 channel activity suppresses proliferation of pancreatic cancer cells (Jager et al., 2004) . The activation of IKCa1 channels is Ca 2 þ -dependent with little or no voltage dependency (Nehrke et al., 2003; Begenisich et al., 2004) . In both AT2.1 and MatLyLu rat prostate cancer cell lines, IKCa1 current densities are comparable to those found in fibroblasts transfected with oncogenic Ras or Raf (Rane, 2000) . Together, these results suggest that IKCa1 channels might be important in regulation of tumor cell proliferation.
We report here that the expression of IKCa1 in human EC specimens was greatly increased compared with that found in atypical hyperplasia tissues and in normal human endometrial specimens. Further, inhibition of IKCa1 channels suppressed proliferation of cultured human EC cells, arrested the cell cycle at G 0 /G 1 phase and restrained growth of EC in nude mice. Our results suggest that IKCa1 channels play a critical role in the development of human EC.
Results

Increased expression of IKCa1 in EC
To explore the role of IKCa1 channels in EC development, we first examined the expression of IKCa1 in both human endometrial specimens and human EC cell lines. As shown in Figure 1a , although the mRNAs for IKCa1 were detectable in some normal human endometrial and atypical hyperplasia specimens, its mRNA levels in most tumor tissues were greatly increased as compared to those in non-tumor tissues. The increased expression of IKCa1 in the tumor specimens was further demonstrated at the protein level by Western blot analysis (Figure 1b and c) . The specificity of the antibody was confirmed by blocking experiments with the antigenic peptides (Supplementary Figure 1) . Furthermore, there was specificity in the increased expression of IKCa1 protein in the specimens because the expression of Kv2.1 proteins, a K þ channel known to mediate the efflux of K þ , was not changed between the tumor and non-tumor tissues (Supplementary Figure 2) . Together, these results provide us initial evidence that IKCa1 channels may play a role in EC development. It has been known that heterogeneity is common to tumors, including EC and that differential expression levels of IKCa1 were evident in different EC cell lines (Supplementary Figure 3) . We thus used HEC-1-A, a well-differentiated EC cell line and KLE, a poorly differentiated EC cell line to explore the role of IKCa1 channels in EC development.
Blocking IKCa1 channels suppressed EC cell growth To investigate whether IKCal channels are possibly involved in EC development, we examined the effect of inhibition of IKCa1 channels on EC cell growth. As shown in Figure 2a , clotrimazole, an inhibitor of IKCa1 channels (Wang et al., 2003; Ahn et al., 2004; Mork et al., 2005) , significantly decreased HEC-1-A cell numbers, as manifested by the right shift of the growth curve. Further, HEC-1-A cell proliferation was suppressed by clotrimazole in a dose-dependent manner (Figure 2b) . Similarly, clotrimazole dose-dependently suppressed the proliferation of KLE cells (Figure 2b) . TRAM-34, another specific inhibitor of IKCa1 channels, also dose-dependently inhibited both HEC-1-A and KLE cell proliferation (Figure 2c ). These results suggest that blockade of IKCa1 channels inhibited EC cell growth.
To provide direct evidence that IKCa1 channels are indeed involved in EC cell proliferation, we specifically knocked down IKCa1 using siRNA against IKCa1. Western blot analysis revealed that the IKCa1 level in the cells transfected with the siRNA was 48.379.1% of that found in the cells transfected with non-silencing RNA (Figure 2d Blocking IKCa1 channels inhibited [ 3 H]thymidine incorporation and arrested EC cell at G 0 /G 1 phase To analyse whether the reduction in EC cell number was due to the decreased cell proliferation, we examined the effect of blocking IKCa1 channels on DNA synthesis in HEC-1-A cells. As shown in Figure 3a , clotrimazole in a dose-dependent manner inhibited [ 3 H]thymidine incorporation in the cells. The [
3 H]thymidine incorporation in HEC-1-A cells transfected with siRNA against IKCa1 was also markedly reduced in comparison with that found in the cells transfected with non-silencing RNA ( Figure 3b ). To elucidate further the mechanism by which inhibiting IKCa1 channels suppresses proliferation of EC cells, we examined the effect of clotrimazole and TRAM-34 on cell-cycle progression of HEC-1-A and KLE cells. In the presence of different concentrations of clotrimazole or TRAM-34 the percentage of HEC-1-A cells in the G 0 /G 1 phase was significantly enhanced, whereas that in the S phase was markedly reduced (Figure 3c-e) . Moreover, the cell-cycle profile of HEC-1-A cells transfected with siRNA against IKCa1 was also characterized by an increase in the percentage of cells in the G 0 /G 1 phase and a reduction of the fraction of the cells in the S phase than those in control (Figure 3f) . Similarly, inhibiting IKCa1 channels by clotrimazole or TRAM-34 and downregulation of IKCa1 by the siRNA arrested KLE cells at the G 0 /G 1 phase (data not shown). Together, these results suggest that IKCa1 channels are important for the proliferation of EC cells.
Presence of functional IKCa1 channels in HEC-1-A Cell
We then examined whether functional IKCa1 channels are present in HEC-1-A cells. Resting membrane potential was first recorded. The membrane potential hyperpolarized with 8.7 mM Ca 2 þ pipette solution was À62.471.9 against À12.571.4 mV, the membrane potential with 1 mM Ca 2 þ pipette solution, indicating the different membrane permeability under different intracellular Ca 2 þ concentrations. Then, ramp currents were elicited by 280 ms voltage ramps from À120 to þ 80 mV (Figure 4a ). The current direction was changed from inward to outward around À72 mV. The same reversal potential was found in either 8.7 or 1 mM Ca 2 þ pipette solution (Figure 4a ), which was consistent with the theoretically calculated E K (Nernst potential of potassium around À80 mV), supporting a K þ -selective conductance. Further, the current density was 42.875.1 pA/pF (n ¼ 15) with 8.7 mM Ca 2 þ pipette solution, whereas, 5.571.4 pA/pF (n ¼ 9) with 1 mM Ca 2 þ pipette solution when membrane potential was at þ 80 mV (inset panel of Figure 4a ). The current density under 8.7 mM Ca 2 þ pipette solution was greatly reduced by In consistent with the results above, downregulation of IKCa1 by siRNA against IKCa1, also markedly reduced the current density (nonsense, n ¼ 13; siRNA against IKCa1, n ¼ 20; *Po0.05, Figure 4d ) induced by the high Ca 2 þ intracellular solution, further supporting the idea that functional IKCa1 channels are in HEC-1-A cells. Therefore, the IKCa1 currents in HEC-1-A cells were indeed induced with a high Ca 2 þ intracellular solution, which facilitated the hyperpolarization of membrane potential. Together, these findings demonstrated that functional IKCa1 channels are present in HEC-1-A cells.
Blocking IKCa1 channels suppressed development of tumor in nude mice To provide direct evidence that IKCa1 channels are responsible for tumor development, we injected HEC-1-A cells to the flank of nude mice with or without IKCa1 inhibitors. At day 17 after injection, all nude mice were killed and the tumors were taken out and blotted out the water. At the macroscopic observation, the difference at the size and volume of the tumors between two groups was marked (Figure 5a ). Injection of TRAM-34 slowed the development of tumor in vivo compared with the controls. The tumor mass of the treated group was 0.2770.13 g, whereas that of control group was 0.570.14 g (Figure 5b ). Furthermore, clotrimazole also slowed the development of tumor in vivo compared with the control. The tumor mass measured in the treated group was 0.4170.19 g, whereas that measured in control group was 0.7270.12 g (Figure 5c ). These results suggest that IKCa1 channels play an important role in the development of EC in vivo.
Discussion
In the present investigation, we have shown that IKCa1 channels play an important role in the development of endometrial tumor and in proliferation of EC cells. Because of their role in cell cycle and their increased expression in EC specimens, IKCa1 channels may thus be a potential target for EC therapy.
It has been shown that the expression of IKCa1 is upregulated in all primary pancreatic cancer tissues tested (Jager et al., 2004) and in response to mitogenic activation of the Ras/ERK signaling pathway (Pena et al., 2000) . Furthermore, clotrimazole inhibits proliferation of human prostate cancer cell lines, such as LNCaP and PC-3 cells (Parihar et al., 2003) . Consistent with these studies, the current work provides IKCa1 channels are responsible for the progression of EC ZH Wang et al new evidence that expression of IKCa1 was also increased in human EC. It is believed that IKCa1 channels are important for keeping the cells hyperpolarized to drive influx of Ca 2 þ via Ca 2 þ -release-activated Ca 2 þ channels (CRAC)-like channels (Legrand et al., 2001) . Calcium ions are regulators of virtually all cellular processes, including cell survival, proliferation, apoptosis and differentiation. Recent studies have shown that the increased growth rate of the cells, including T-lymphocytes and prostate cancer cells, is correlated with an increase in Ca 2 þ pool filling (Lu et al., 1999) . It has been demonstrated that IKCa1 channels can enhance Ca 2 þ entry by membrane hyperpolarization in human erythroleukemia cell line (Rane, 1999) . Therefore, one plausible explanation for the fact that IKCa1 channels were responsible for the proliferation of EC cells is that IKCa1 channels regulate the membrane potential to modulate Ca 2 þ influx through CRAC-like channels to affect the proliferation of EC cells. Our findings that clotrimazole or TRAM-34 blocked the IKCa1 current and cell proliferation in HEC-1-A cells are consistent with this explanation.
It has been known that cells in the early G 1 phase are depolarized; however, they are hyperpolarized during the progression through G 1 into the S phase (Wang et al., 1998; Ghanshani et al., 2000) . Inhibition of K þ channels leads to membrane depolarization and cellcycle arrest in early G 1 phase in the MCF-7 human breast carcinoma cell line (Wang et al., 1998) . Conversely, activation of K þ channels promotes the cellcycle progression from the G 0 /G 1 to S phase (Wonderlin et al., 1995; Ouadid-Ahidouch et al., 2001; Chittajallu et al., 2002) . Here, we demonstrated that the activity of IKCa1 channels contributed to the progression of EC cells through the G 1 phase in the G 1 /S transition.
In this context, IKCa1 channels play an important role in controlling EC cell cycle and cell growth. It is possible that inhibiting IKCa1 channels induces membrane depolarization to reduce the driving force for Ca 2 þ influx, leading to G 0 /G 1 arrest and inhibition of cell proliferation. It has been reported that clotrimazole pipette solution (n ¼ 9) and 8.7 mM Ca 2 þ pipette solution (n ¼ 15) was shown in inset. **Po0.01 versus control. (b) The K þ current elicited by 8.7 mM Ca 2 þ pipette solution was blocked by clotrimazole (n ¼ 5) and charybdotoxin (n ¼ 5) in a dose-dependent manner. Traces shown were obtained in a bath solution before and after application of clotrimazole (10 and 20 mM) and charybdotoxin (100 and 300 nM). (c) The K þ current elicited by 8.7 mM Ca 2 þ pipette solution was blocked by TRAM-34 (n ¼ 6), a specific inhibitor to IKCa1 channels. Traces shown were obtained in a bath solution before and after application of 10 mM TRAM-34. (d) The K þ current elicited with 8.7 mM Ca 2 þ pipette solution at membrane potential þ 80 mV was blocked by clotrimazole (n ¼ 5), charybdotoxin (n ¼ 5) and TRAM-34 (n ¼ 6). Knockdown of IKCa1 with the siRNA (nonsense n ¼ 13, siRNA against IKCa1 n ¼ 20) also reduced K þ current densities at membrane potential þ 80 mV. *Po0.05, **Po0.01 versus control.
IKCa1 channels are responsible for the progression of EC ZH Wang et al may also inhibit the activity of cytochrome P450 enzymes. The effect of clotrimazole on the cell growth was not a result of its known effect on inhibiting cytochrome P450 enzymes, because TRAM-34, which does not affect P450 enzymes, had the similar effect on the changes in cell number and cell cycle. Therefore, inhibitors of IKCa1 channels can be possibly used as adjuvant chemotherapeutic reagents in anti-EC therapy.
In summary, we have shown that IKCa1 channels are proliferative molecules in EC cells. Higher expression of IKCa1 has been found in clinical EC specimens than that in normal human endometrial specimens. Thus IKCa1 channels may be a new target for treatment of EC.
Materials and methods
Materials
Antibodies against IKCa1, Kv2. 1 and GAPDH were purchased from Sigma (St Louis, MO, USA); clotrimazole, TRAM-34 and CTX were from Sigma; [methyl-3 H]thymidine from NEN (Boston, MA, USA); propidium iodide (PI) was from Molecular Probes (Eugene, OR, USA); RNase A was from Roche Diagnostics (Mannheim, Germany); and TRIzol was from Invitrogen (Carlsbad, CA, USA). All other reagents were from Sigma.
Biological samples
Twenty-five EC biopsies were obtained with the patients' consent from the patients registered at the Hospital of Obstetrics and Gynecology in Medical Center of Fudan University or the First People's Hospital of Shanghai and the Cancer Hospital of Fudan University following the local ethical consideration. The biopsies from patients who had not received any anticancer therapy (chemotherapy, radiotherapy, hormone therapy or surgery) were studied. The EC samples were diagnosed as adenocarcinoma, according to the International Federation of Gynecology and Obstetrics (FIGO), patients with stages I-III accounted for 76% (19/25), 20% (5/25) and 4% (1/25), respectively. Twenty-six atypical hyperplasia biopsies and 25 normal endometrial biopsies were obtained with the patients' consent by hysterectomy and diagnosed as benign tissue from patients registered at the hospitals. The tissue fragment about 0.5 cm 3 was obtained and then divided into two parts for total RNA isolation and protein extraction.
Cell culture
Four human EC cell lines, HEC-1-A, KLE and RL95-2 (American Type Culture Collection) and Ishikawa (Sigma) were cultured in Dulbecco's modified Eagle's medium (DMEM)/Ham's F12 medium (F12) supplemented with 10% heat-inactivated fetal bovine serum and maintained continuously in a humidified, 5% CO 2 incubator at 371C. For some experiments, cells seeded in 60-or 35-mm dishes at a density of 1-2 Â 10 5 or 5 Â 10 4 cells per dish for 24 h were incubated in the medium containing different concentrations of clotrimazole or TRAM-34. The cells were then harvested and cell numbers were counted using the COULTERt (Beckman, Fullerton, CA, USA).
Reverse transcription and real-time polymerase chain reaction Total RNA (5 mg) extracted from the specimens with TRIzol was reverse-transcripted into cDNA for real-time polymerase chain reaction (PCR) analysis. The following primer pairs were used for real-time PCR: GAPDH: (sense), 5 0 -ATGGG 0 . Real-time PCR analysis was performed on ABI PRISM 7000 Sequence Detection System in a reaction containing 12.5 ml of (2 Â ) SYBR Premix Ex Taq TM (TaKaRa Biotechnology, China), 200 nM of the primers and 1 ml template cDNA in a total volume of 25 ml. The PCR was performed as following: polymerase activation at 951C for 10 s followed by 40 cycles at 951C for 5 s and 601C for 31 s. A dissociation protocol was added after thermocycling to verify the specificity of the target amplification. Quantification was performed using the comparative C T method (DDC T method) as provided by the manufacturer (Applied Biosystems, Foster City, CA, USA). The cycle number at which the reaction crossed a threshold (C T ) was determined for the endogenous control (GAPDH) and target (IKCa1). The relative amount of IKCa1, normalized to the endogenous control and relative to a common reference sample, was calculated by the formula 2
ÀDDCT
. The reaction for the GAPDH and IKCa1 was carried out in triplicate for each sample. Mice tumor model All nude mice were kept under standard laboratory conditions (temperature 20-241C, relative humidity 50-60%, 12 h light/ dark cycle). Three-week-old female mice were housed three per cage, fed with sterile food and water. A total of 36 female nude mice were randomly divided into control and treated groups. Because clotrimazole can induce a long silent period in channel activity (Dunn, 1998) , treated groups were injected with 8 Â 10 6 HEC-1-A cells with 20 mM clotrimazole or 30 mM TRAM-34 into the flank of the mice, and control groups injected with 8 Â 10 6 HEC-1-A cells and 0.4 ml dimethyl sulfoxide. The mice were killed and the tumors were taken out 16 days after injection. The tumor size was measured in mass with a scale.
Statistical analysis
Multiple comparisons were assessed by one-way analysis of variance in non-parametric statistics; otherwise Student's unpaired t-test was used for statistical analysis. Results were considered significant difference at *Po0.05; **Po0.01.
